The Conflict Between Human Rights And Biotechnological Evolution
By Srinivas Raman,
Eurasia Review
| 04. 11. 2015
Untitled Document
In 1997, Dolly the sheep became the first mammal ever to be successfully cloned. This was a major breakthrough in the field of genetic engineering and since then scientists worldwide have been trying to replicate the success in other mammals such as pigs, mice, cows, primates and even humans. However, the idea of genetic modification by using biotechnology existed way before Dolly did and was a cornerstone to the Nazi ideology and eugenics was used as a justification to commit heinous crimes against humanity such as genocide.[1]
Today, one of the most perilous issues but unfortunately one which has gained scarce global attention is whether humans should be genetically modified. This question raises several moral, ethical, legal and scientific considerations and is an extremely sensitive issue. The startling contemporary truth is that technology is at a stage where it is possible for scientists to clone humans and genetically engineer them.[2]
Genetically modifying humans has the potential to violate human rights and freedom and could possibly lead to catastrophic consequences for the human race if legalized and encouraged. Manipulating...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...